Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Hair cortisol is a reliable stress indicator in cattle but may not be valid for pigs.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Eating healthy, exercising, and certain nutrients like myoinositol and omega-3s can help manage PCOS symptoms.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.